ArticleBioMed research international2023

Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway.

BioMed Research InternationalPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.